Cancer Immunology and Immunotherapy

Cellular immunity depends mainly on the power of DCs to require up and process antigens within the peripheral blood and tissues. In cancer, this process isn't robust enough to supply meaningful antitumor responses. Monoclonal antibodies are proteins produced by B-cells that bind to a selected antigen. they're currently one among the foremost successful sorts of cancer immunotherapy. we should always differentiate between monoclonal antibody-based cancer therapy and monoclonal antibody-based immunotherapy of cancer. this will be illustrated by the differences in their mechanisms of action. Anti-neoplastic agents like bevacizumab block ligand–receptor interaction, thereby affecting growth or survival pathways, where monoclonal antibodies like rituximab cause antibody-dependent cellular cytotoxicity and complement-mediated cytotoxicity. Antibodies also are getting used to reinforce the strength of the immune reaction. As mentioned earlier, activated T-cells and tumour cells express CTLA4 receptors as an immune-suppressive mechanism to guard against autoimmunity and to flee elimination. Antagonism of those receptors has shown antitumor benefit. for instance, ipilimumab inhibits the receptor CTLA4, permitting persistent T-cell activation. Similarly, PD1 is expressed on activated T- and B-cells and when sure to by PD1 ligand they become deactivated (10-12). Tumour cells tend to overexpress PD1 ligands, allowing them to deactivate this response.

  • Cell-based immunotherapy of cancer
  • Antibody-based immunotherapy of cancer
  • Cytokine-based immunotherapy of cancer
  • Anti CTLA4
  • Anti-PD1
  • Hodgkin's lymphoma

    Related Conference of Cancer Immunology and Immunotherapy

    April 16-17, 2025

    9th International Conference on Internal Medicine

    Berlin, Germany
    May 12-13, 2025

    19th International Conference on Obesity Medicine

    Toronto, Canada
    June 24-25, 2025

    3rd Global Summit on HIV-AIDS and STDs

    Chicago, USA
    July 21-22, 2025

    24th International Conference on Genomics and Molecular Biology

    Aix-en-Provence, France
    August 07-08, 2025

    12th World Summit on Epilepsy and Bipolar Disorders

    Paris, France
    August 25-26, 2025

    8th International Conference on Community Nursing and Public Health

    Singapore City, Singapore
    September 22-23, 2025

    39th International Conference on Cancer Science & Therapy

    Amsterdam, Netherlands
    September 22-23, 2025

    17th Annual Congress on Drug Formulation & Analytical Techniques

    Amsterdam, Netherlands
    October 16-17, 2025

    19th International Conference on Pathology and Laboratory Medicine

    Aix-en-Provence, France
    November 03-04, 2025

    5th World Medicine Congress

    Rome, Italy

    Cancer Immunology and Immunotherapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in